AUBREY DOWNEY: Open Payments
NPI 1639759525 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,824 in 79 payments from 22 companies in 2025. Trend: 2023 $2,354 · 2024 $3,515 · 2025 $1,824
Food & beverage: $1,824
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $285 |
| LEO Pharma Inc. | 8 | $237 |
| ABBVIE INC. | 15 | $235 |
| UCB, Inc. | 5 | $210 |
| GENZYME CORPORATION | 5 | $168 |
| Organon LLC | 11 | $80 |
| PFIZER INC. | 4 | $79 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $55 |
| KYOWA KIRIN, INC. | 2 | $49 |
Products named: DUPIXENT, ADBRY, Bimzelx, SKYRIZI, CIBINQO, COSENTYX, RINVOQ, VTAMA.
Industry payments across AZ — which companies pay providers there.
